Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Coherent, Inc.
Coherent, Inc. Reports Third Fiscal Quarter Results
August 17th, 2008
Coherent, Inc. (NASDAQ:COHR) announced financial results for its third fiscal quarter ended June 28, 2008, posting net sales of $157.0 million and net income, on a U.S. generally accepted accounting principles (GAAP) basis, of $8.4 million or $0.35 per diluted share compared to net sales of $142.6 million and a net loss of $0.8 million or ($0.02) per diluted share for the third quarter of fiscal 2007. Net income for the third quarter of fiscal 2008 included an after tax charge of $0.9 million related to litigation resulting from our internal stock option investigation ($0.04 per diluted share), after tax stock-related compensation expense of $2.0 million ($0.08 per...
Source: Pharma Investments, Ventures & Law Weekly (2008-08-17)
|
